Review<\/p>\n
Affiliations Expand <\/p>\n
Item in Clipboard<\/p>\n
Review<\/p>\n
Adriana Rendonet al. Int J Mol Sci. 2019. <\/p>\n
Display options <\/p>\n
Format Abstract PubMed PMID <\/p>\n
Item in Clipboard<\/p>\n
Display options <\/p>\n
Format AbstractPubMedPMID<\/p>\n
Research on psoriasis pathogenesis has largely increased knowledge on skin biology in general. In the past 15 years, breakthroughs in the understanding of the pathogenesis of psoriasis have been translated into targeted and highly effective therapies providing fundamental insights into the pathogenesis of chronic inflammatory diseases with a dominant IL-23\/Th17 axis. This review discusses the mechanisms involved in the initiation and development of the disease, as well as the therapeutic options that have arisen from the dissection of the inflammatory psoriatic pathways. Our discussion begins by addressing the inflammatory pathways and key cell types initiating and perpetuating psoriatic inflammation. Next, we describe the role of genetics, associated epigenetic mechanisms, and the interaction of the skin flora in the pathophysiology of psoriasis. Finally, we include a comprehensive review of well-established widely available therapies and novel targeted drugs. <\/p>\n
Keywords: chronic skin disease; inflammation; psoriasis. <\/p>\n
The authors declare no conflict of interest.<\/p>\n
Figure 1 <\/p>\n
Clinical manifestations of psoriasis. ( <\/p>\n
Figure 1 <\/p>\n
Clinical manifestations of psoriasis. ( A , B ) Psoriasis vulgaris presents with <\/p>\n
Clinical manifestations of psoriasis. (A,B) Psoriasis vulgaris presents with erythematous scaly plaques on the trunk and extensor surfaces of the limbs. (C) Generalized pustular psoriasis. (D) Pustular psoriasis localized to the soles of the feet. This variant typically affects the palms of the hands as well; hence, psoriasis pustulosa palmoplantaris. (E,F) Inverse psoriasis affects the folds of the skin (i.e., axillary, intergluteal, inframammary, and genital involvement).<\/p>\n
Figure 1 <\/p>\n
Clinical manifestations of psoriasis. ( <\/p>\n
Figure 1 <\/p>\n
Clinical manifestations of psoriasis. ( A , B ) Psoriasis vulgaris presents with <\/p>\n
Clinical manifestations of psoriasis. (A,B) Psoriasis vulgaris presents with erythematous scaly plaques on the trunk and extensor surfaces of the limbs. (C) Generalized pustular psoriasis. (D) Pustular psoriasis localized to the soles of the feet. This variant typically affects the palms of the hands as well; hence, psoriasis pustulosa palmoplantaris. (E,F) Inverse psoriasis affects the folds of the skin (i.e., axillary, intergluteal, inframammary, and genital involvement).<\/p>\n
Erythrodermic psoriasis.<\/p>\n
Figure 3 <\/p>\n
Onycholysis and oil drop changes <\/p>\n
Figure 3 <\/p>\n
Onycholysis and oil drop changes on psoriatic nail involvement. <\/p>\n
Onycholysis and oil drop changes on psoriatic nail involvement.<\/p>\n
Figure 4 <\/p>\n
Histopathology of psoriasis. ( A <\/p>\n
Figure 4 <\/p>\n
Histopathology of psoriasis. ( A ) Psoriasis vulgaris characteristically shows acanthosis, parakeratosis, and <\/p>\n
Histopathology of psoriasis. (A) Psoriasis vulgaris characteristically shows acanthosis, parakeratosis, and dermal inflammatory infiltrates. (B) In pustular psoriasis, acanthotic changes are accompanied by epidermal predominantly neutrophilic infiltrates, which cause pustule formation.<\/p>\n
Figure 5 <\/p>\n
The pathogenesis of psoriasis. <\/p>\n
Figure 5 <\/p>\n
The pathogenesis of psoriasis. <\/p>\n
The pathogenesis of psoriasis.<\/p>\n
Boehncke WH, Brembilla NC. Boehncke WH, et al. Clin Rev Allergy Immunol. 2018 Dec;55(3):295-311. doi: 10.1007\/s12016-017-8634-3. Clin Rev Allergy Immunol. 2018. PMID: 28780731 Review. <\/p>\n
Schleicher SM. Schleicher SM. Clin Podiatr Med Surg. 2016 Jul;33(3):355-66. doi: 10.1016\/j.cpm.2016.02.004. Epub 2016 Mar 25. Clin Podiatr Med Surg. 2016. PMID: 27215156 Review. <\/p>\n
Ko JM, Qureshi AW. Ko JM, et al. G Ital Dermatol Venereol. 2010 Jun;145(3):393-406. G Ital Dermatol Venereol. 2010. PMID: 20461047 Review. <\/p>\n
Blauvelt A, Chiricozzi A. Blauvelt A, et al. Clin Rev Allergy Immunol. 2018 Dec;55(3):379-390. doi: 10.1007\/s12016-018-8702-3. Clin Rev Allergy Immunol. 2018. PMID: 30109481 Free PMC article. Review. <\/p>\n
Mrowietz U, Reich K. Mrowietz U, et al. Dtsch Arztebl Int. 2009 Jan;106(1-2):11-8, quiz 19. doi: 10.3238\/arztebl.2009.0011. Epub 2009 Jan 5. Dtsch Arztebl Int. 2009. PMID: 19564982 Free PMC article. Review. <\/p>\n
Lu YW, Chen YJ, Shi N, Yang LH, Wang HM, Dong RJ, Kuang YQ, Li YY. Lu YW, et al. Front Immunol. 2022 Sep 12;13:971071. doi: 10.3389\/fimmu.2022.971071. eCollection 2022. Front Immunol. 2022. PMID: 36172384 Free PMC article. <\/p>\n
Wang Z, Zhang HM, Guo YR, Li LL. Wang Z, et al. World J Clin Cases. 2022 Jul 26;10(21):7224-7241. doi: 10.12998\/wjcc.v10.i21.7224. World J Clin Cases. 2022. PMID: 36158000 Free PMC article. <\/p>\n
Andjar I, Esplugues JV, Garca-Martnez P. Andjar I, et al. Pharmaceuticals (Basel). 2022 Sep 3;15(9):1101. doi: 10.3390\/ph15091101. Pharmaceuticals (Basel). 2022. PMID: 36145322 Free PMC article. Review. <\/p>\n
Olunoiki E, Rehner J, Bischoff M, Koshel E, Vogt T, Reichrath J, Becker SL. Olunoiki E, et al. Life (Basel). 2022 Sep 12;12(9):1420. doi: 10.3390\/life12091420. Life (Basel). 2022. PMID: 36143456 Free PMC article. Review. <\/p>\n
Nijakowski K, Gruszczyski D, Kolasiska J, Kopaa D, Surdacka A. Nijakowski K, et al. Int J Environ Res Public Health. 2022 Sep 8;19(18):11302. doi: 10.3390\/ijerph191811302. Int J Environ Res Public Health. 2022. PMID: 36141573 Free PMC article. Review. <\/p>\n
Show all 217 references <\/p>\n
<\/p>\n
Original post: Review Affiliations Expand Item in Clipboard Review Adriana Rendonet al. Int J Mol Sci. 2019 Continue reading
\nPsoriasis Pathogenesis and Treatment - PubMed<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"